Differential effects of GABA analogues and zinc on glutamate decarboxylase, 4-aminobutyric-2-oxoglutaric acid transaminase and succinate semialdehyde dehydrogenase in rat brain tissue.
D000612:4-Aminobutyrate Transaminase / Q000378:metabolism*; D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D001547:Benzaldehydes / Q000494:pharmacology; D001921:Brain / Q000201:enzymology*; D002262:Carboxy-Lyases / Q000378:metabolism*; D005968:Glutamate Decarboxylase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D011760:Pyrrolidinones / Q000494:pharmacology; D051381:Rats; D013385:Succinate Dehydrogenase / Q000378:metabolism*; D000637:Transaminases / Q000378:metabolism*; D015032:Zinc / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives*
D000613:Aminobutyrates; D001547:Benzaldehydes; D011760:Pyrrolidinones; D005680:gamma-Aminobutyric Acid; D013385:Succinate Dehydrogenase; D000637:Transaminases; D000612:4-Aminobutyrate Transaminase; D002262:Carboxy-Lyases; D005968:Glutamate Decarboxylase; D015032:Zinc